Can atrial fibrillation cause fatal arrhythmias?

Can Atrial Fibrillation Cause Fatal Arrhythmias?

Yes, atrial fibrillation can cause fatal arrhythmias, particularly in patients with Wolff-Parkinson-White syndrome where AF can degenerate into ventricular fibrillation and sudden cardiac death. 1

Critical Life-Threatening Scenario: WPW Syndrome

In patients with Wolff-Parkinson-White (WPW) syndrome and overt pre-excitation, AF represents a potentially life-threatening arrhythmia 1. The mechanism is clear and dangerous:

• Accessory pathways lack the decremental conduction properties of the AV node
• AF can conduct rapidly across the accessory pathway, producing extremely fast ventricular rates (often >200 bpm)
• This rapid ventricular response can degenerate into ventricular fibrillation, causing sudden cardiac death 1

Management is unequivocal: Catheter ablation of the accessory pathway is recommended (Class I, Level A) to prevent sudden cardiac death 1. This is particularly urgent for patients who have survived sudden cardiac death or those in high-risk professions 1.

Critical Pitfall to Avoid

Never administer AV nodal blocking agents (digoxin, diltiazem, verapamil, or beta-blockers) in patients with pre-excited AF, as these can paradoxically increase conduction through the accessory pathway and precipitate ventricular fibrillation 2.

AF and Ventricular Arrhythmias in the General Population

Beyond WPW syndrome, emerging evidence demonstrates that AF independently increases the risk of fatal ventricular arrhythmias:

• AF is associated with a 3-fold increased risk of ventricular fibrillation in the general population, independent of comorbidities, antiarrhythmic drugs, or acute MI 3
• A meta-analysis showed AF patients have a 2-fold increased risk of sudden cardiac death (pooled risk ratio 2.04,95% CI: 1.77-2.35) 4
• The rapid and irregular rhythm of AF, particularly the short-long-short cycles, increases susceptibility to ventricular tachycardia and ventricular fibrillation 5

Recent mechanistic research 6 demonstrates that AF promotes ventricular proarrhythmic activity through oxidative stress pathways, providing biological plausibility for this association.

Clinical Context and Risk Stratification

The risk of fatal arrhythmias in AF varies by clinical context:

High-Risk Populations:

• WPW syndrome with pre-excitation - immediate life-threatening risk 1
• Hypertrophic cardiomyopathy with AF 1, 7
• Heart failure patients with AF 4
• Post-myocardial infarction with AF 4

Moderate Risk:

• General population with AF - 2-fold increased SCD risk 4
• AF with left ventricular hypertrophy 5

Practical Management Algorithm

For patients presenting with AF:

1. Immediately assess for pre-excitation on ECG (delta waves, short PR interval)

   • If present → urgent electrophysiology referral for ablation 1
   • Avoid all AV nodal blocking agents 2

2. Evaluate for structural heart disease (HCM, heart failure, prior MI)

   • These patients have compounded risk of sudden death 4
   • Consider ICD evaluation in appropriate candidates 7

3. Monitor for bradycardia-tachycardia syndrome

   • Bradycardia-related long-short-long sequences can trigger ventricular arrhythmias 8
   • May require pacing at 80-110 bpm to prevent VAs 8

Key Takeaway

While AF itself is primarily a supraventricular arrhythmia 9, it creates conditions that promote fatal ventricular arrhythmias through multiple mechanisms. The most dramatic and immediately life-threatening scenario occurs in WPW syndrome, where catheter ablation is lifesaving. In the broader AF population, the 2-3 fold increased risk of sudden cardiac death warrants careful risk stratification and management of underlying cardiac conditions.